YZYan Zhang

Yan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yan Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • De-E Wei

    Department of Cardiology, The Central Hostpital of Jinan City of Shandong University, Jinan, 250013, China

    1 shared publication
  • Lin-Lin Guo

    Department of Cardiology, The Second Hospital of Shandong University, Jinan, 250033, China

    1 shared publication
  • Pei-Li Bu

    Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital, Jinan, 250012, China

    1 shared publication
  • Wei-Hong Ma

    Department of Cardiology, The Second Hospital of Shandong University, Jinan, 250033, China

    1 shared publication
  • Xiu-Ling Wang

    Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital, Jinan, 250012, China

    1 shared publication
  • Yibiao Wang

    Department of Pediatrics, The Second Hospital of Shandong University, Jinan, China

    1 shared publication

Latest Publications

  • Open Access

    Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension

    by Wei-Hong Ma, Xiu-Ling Wang, Yi-Meng Du, Yi-Biao Wang, Yan Zhang, De-E Wei, Lin-Lin Guo, Pei-Li Bu

    Background: YKL-40, a proposed marker of inflammation and endothelial dysfunction, is associated with atherosclerosis and an increased cardiovascular mortality in the general population. However, the relationship between YKL-40 and arterial stiffness in hypertensive patients has not been adequately assessed. Methods: The relationship between serum levels of YKL-40 and arterial stiffness was evaluated in 93 essential hypertensive subjects and 80 normal subjects. Essential hypertensive subjects were divided into two groups based upon urinary albumin-to-creatinine ratio (ACR): nonmicroalbuminuric group, (ACR n = 50) and microalbuminuric group (ACR ≥30 mg/g, n = 43). Large artery wall stiffness was assessed by measuring femoral arterial stiffness and carotid-femoral pulse wave velocity (cf-PWV). Serum levels of YKL-40 were determined by enzyme-linked immunosorbent assay (ELISA). Results: The study demonstrated that YKL-40,cf-PWV and femoral arterial stiffness were increased significantly (PPr = 0.44, P = 0.000) and femoral arterial stiffness ( r = 0.42, P =0.001). Multiple linear stepwise regression analysis showed that YKL-40 was the impact factor of arterial stiffness ( P<0.05). Conclusion: YKL-40 levels are elevated in essential hypertension subjects with an independent association between increasing YKL-40 levels and increasing arterial stiffness. The study suggests it played a positive role of YKL-40 in the progressing vascular complications in patients with essential hypertension.